A carregar...

Stopping screening, when and how?

Screening for prostate cancer (PC) is still controversial despite randomized trials has found that PC mortality is decreased. The major concern is the high rate of over-diagnosis and subsequent harms that may follow in many men who never would have had any symptoms during life-time if not screened....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Autor principal: Hugosson, Jonas
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861277/
https://ncbi.nlm.nih.gov/pubmed/29594019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.12.39
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!